Luminex Corp. (LMNX) SVP Buys $74,620.00 in Stock
Luminex Corp. (NASDAQ:LMNX) SVP Harriss T. Currie purchased 4,100 shares of Luminex Corp. stock in a transaction on Thursday, November 3rd. The stock was bought at an average cost of $18.20 per share, for a total transaction of $74,620.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of Luminex Corp. (NASDAQ:LMNX) opened at 20.49 on Thursday. Luminex Corp. has a 12 month low of $17.29 and a 12 month high of $23.75. The firm has a market cap of $893.04 million, a price-to-earnings ratio of 23.63 and a beta of 0.57. The stock’s 50 day moving average price is $21.58 and its 200 day moving average price is $21.09.
Luminex Corp. (NASDAQ:LMNX) last posted its quarterly earnings results on Monday, October 31st. The company reported $0.21 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.12 by $0.09. Luminex Corp. had a return on equity of 11.95% and a net margin of 14.51%. The firm earned $71.20 million during the quarter, compared to the consensus estimate of $68.90 million. During the same quarter in the previous year, the business earned $0.22 earnings per share. The firm’s quarterly revenue was up 17.5% compared to the same quarter last year. Equities research analysts predict that Luminex Corp. will post $0.52 earnings per share for the current fiscal year.
A number of large investors have recently bought and sold shares of LMNX. American International Group Inc. increased its stake in Luminex Corp. by 0.5% in the third quarter. American International Group Inc. now owns 29,519 shares of the company’s stock worth $671,000 after buying an additional 158 shares during the period. Emerald Acquisition Ltd. increased its stake in Luminex Corp. by 11.0% in the third quarter. Emerald Acquisition Ltd. now owns 259,522 shares of the company’s stock worth $5,896,000 after buying an additional 25,762 shares during the period. California State Teachers Retirement System increased its stake in Luminex Corp. by 1.0% in the third quarter. California State Teachers Retirement System now owns 84,077 shares of the company’s stock worth $1,910,000 after buying an additional 800 shares during the period. Cowen Prime Services LLC increased its stake in Luminex Corp. by 1.0% in the third quarter. Cowen Prime Services LLC now owns 256,945 shares of the company’s stock worth $5,838,000 after buying an additional 2,600 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in Luminex Corp. during the third quarter worth about $143,000. 78.20% of the stock is owned by hedge funds and other institutional investors.
A number of equities research analysts have issued reports on LMNX shares. Zacks Investment Research raised Luminex Corp. from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research report on Tuesday, July 26th. Jefferies Group increased their price target on Luminex Corp. from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Thursday, July 28th. William Blair reaffirmed a “market perform” rating on shares of Luminex Corp. in a research report on Tuesday, November 1st. JPMorgan Chase & Co. raised Luminex Corp. from an “underweight” rating to a “neutral” rating and increased their price target for the company from $18.00 to $22.00 in a research report on Thursday, August 18th. Finally, Avondale Partners initiated coverage on Luminex Corp. in a research report on Wednesday, October 12th. They issued an “outperform” rating and a $27.00 price target on the stock. Six research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $23.00.
Luminex Corp. Company Profile
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company’s FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry.
Receive News & Stock Ratings for Luminex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corp. and related stocks with our FREE daily email newsletter.